NEDD4 Knockdown Suppresses Human Endometrial Stromal Cell Growth and Invasion by Regulating PTGS2-Mediated Ferroptosis in Endometriosis
other
OA: closed
public-domain-us
AI-generated summary
NEDD4 knockdown suppressed human endometrial stromal cell growth and invasion by increasing PTGS2-mediated ferroptosis, as NEDD4 targets PTGS2 for ubiquitination and degradation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Endometriosis (EM) is a gynecological disease characterized by the benign growth of endometrial tissue outside the uterus. Upregulation of neuronally expressed developmentally downregulated 4 (NEDD4) has been reported to accelerate endometrial cancer progression.
OBJECTIVES: We explored whether abnormal expression of NEDD4 is correlated with EM.
METHODS: Endometrial tissue in patients without endometriosis was used to develop the original generation of endometrial stromal cells (ESCs). Different types of endometrial tissue of patients with endometriosis were used to measure the expression of NEDD4 by immunohistochemistry (IHC) and western blotting. Its biological functions in ESCs were investigated using a cell counting kit-8 assay, fluorescein diacetate (FDA) staining, and Transwell invasion assays. Additionally, its involvement in ferroptosis was assessed by measuring Fe2+, malondialdehyde (MDA), glutathione (GSH), and reactive oxygen species (ROS) levels and the expression of ferroptosis markers.
RESULTS: Compared with normal controls, NEDD4 levels were significantly elevated in the endometrial tissue of patients with EM. Furthermore, NEDD4 expression was higher in the ectopic endometrium than in the eutopic endometrium. NEDD4 knockdown reduced the viability and invasive capacity of ESCs, increased Fe2+, MDA, and ROS levels, and decreased GSH content. Further analysis revealed that NEDD4 knockdown promoted ferroptosis in ESCs by increasing the expression of prostaglandin-endoperoxide synthase 2 (PTGS2). As an E3 ubiquitin ligase, NEDD4 reduced PTGS2 protein levels by accelerating its ubiquitination and subsequent proteasomal degradation.
CONCLUSION: These findings suggest that inhibiting NEDD4 reduces ESC growth and invasion in EM by regulating PTGS2-dependent ferroptosis.
Full text
6,694 characters
· extracted from
oa-doi-fallback
· 6 sections
· click to expand
Abstract
Background: Endometriosis (EM) is a gynecological disease characterized by the benign growth of endometrial tissue outside the uterus. Upregulation of neuronally expressed developmentally downregulated 4 (NEDD4) has been reported to accelerate endometrial cancer progression.
Objectives
We explored whether abnormal expression of NEDD4 is correlated with EM.
Methods
Endometrial tissue in patients without endometriosis was used to develop the original generation of endometrial stromal cells (ESCs). Different types of endometrial tissue of patients with endometriosis were used to measure the expression of NEDD4 by immunohistochemistry (IHC) and western blotting. Its biological functions in ESCs were investigated using a cell counting kit-8 assay, fluorescein diacetate (FDA) staining, and Transwell invasion assays. Additionally, its involvement in ferroptosis was assessed by measuring Fe2+, malondialdehyde (MDA), glutathione (GSH), and reactive oxygen species (ROS) levels and the expression of ferroptosis markers.
Results
Compared with normal controls, NEDD4 levels were significantly elevated in the endometrial tissue of patients with EM. Furthermore, NEDD4 expression was higher in the ectopic endometrium than in the eutopic endometrium. NEDD4 knockdown reduced the viability and invasive capacity of ESCs, increased Fe2+, MDA, and ROS levels, and decreased GSH content. Further analysis revealed that NEDD4 knockdown promoted ferroptosis in ESCs by increasing the expression of prostaglandin-endoperoxide synthase 2 (PTGS2). As an E3 ubiquitin ligase, NEDD4 reduced PTGS2 protein levels by accelerating its ubiquitination and subsequent proteasomal degradation.
Conclusion
These findings suggest that inhibiting NEDD4 reduces ESC growth and invasion in EM by regulating PTGS2-dependent ferroptosis.
Keywords
NEDD4, PTGS2, endometriosis, ferroptosis, endometrial stromal cells, cell viability.
[http://dx.doi.org/10.3389/frph.2021.729642] [PMID: 36303969]
[http://dx.doi.org/10.1038/s41574-019-0245-z] [PMID: 31488888]
[http://dx.doi.org/10.1186/s12967-020-02471-0] [PMID: 32787880]
[http://dx.doi.org/10.1136/bmj-2022-070750] [PMID: 36375827]
[http://dx.doi.org/10.1016/S0140-6736(21)00389-5] [PMID: 33640070]
[http://dx.doi.org/10.1007/s00404-020-05586-3] [PMID: 32430756]
[http://dx.doi.org/10.1007/s00404-021-06129-0] [PMID: 34148122]
[http://dx.doi.org/10.3389/fmed.2022.879015] [PMID: 35572957]
[http://dx.doi.org/10.1146/annurev-pathmechdis-012419-032654] [PMID: 31479615]
[http://dx.doi.org/10.1016/S0002-9378(15)30003-X]
[http://dx.doi.org/10.1136/bmj-2021-068950] [PMID: 36442873]
[http://dx.doi.org/10.1016/S0015-0282(02)03346-0] [PMID: 12372445]
[http://dx.doi.org/10.3390/ijms24021619] [PMID: 36675136]
[http://dx.doi.org/10.1016/j.tox.2021.153050] [PMID: 34826546]
[http://dx.doi.org/10.3390/biomedicines8110454] [PMID: 33121166]
[http://dx.doi.org/10.1186/s12943-022-01530-y] [PMID: 35151318]
[http://dx.doi.org/10.1016/j.redox.2017.01.021] [PMID: 28212525]
[http://dx.doi.org/10.1038/s41580-020-00324-8] [PMID: 33495651]
[http://dx.doi.org/10.1007/s00011-022-01672-1] [PMID: 36536250]
[http://dx.doi.org/10.1016/j.ejcb.2019.151058] [PMID: 31810634]
[http://dx.doi.org/10.1111/cpr.12761] [PMID: 32100402]
[http://dx.doi.org/10.3390/cells8020198] [PMID: 30813496]
[http://dx.doi.org/10.1038/s41598-022-04963-z] [PMID: 35173188]
[http://dx.doi.org/10.1038/s41580-023-00648-1] [PMID: 37783783]
[http://dx.doi.org/10.1155/2017/7265238] [PMID: 29057034]
[http://dx.doi.org/10.1007/s43032-020-00164-z] [PMID: 32077077]
[http://dx.doi.org/10.1038/d41586-021-01203-8] [PMID: 33981062]
[http://dx.doi.org/10.1016/j.biopha.2018.06.109] [PMID: 29958140]
[http://dx.doi.org/10.3389/fphys.2021.702674] [PMID: 34712146]
[http://dx.doi.org/10.1016/j.biopha.2020.109983] [PMID: 32092816]
[http://dx.doi.org/10.7150/ijbs.48437] [PMID: 33110392]
[http://dx.doi.org/10.3390/ijms23073882] [PMID: 35409239]
[http://dx.doi.org/10.1016/j.semcancer.2020.03.006] [PMID: 32171886]
[http://dx.doi.org/10.1038/s41467-020-14324-x] [PMID: 31974380]
[http://dx.doi.org/10.1016/j.jdermsci.2023.09.007] [PMID: 37932175]
[http://dx.doi.org/10.1111/cns.14685] [PMID: 38634270]
[http://dx.doi.org/10.1016/j.bbrc.2020.07.032] [PMID: 32811647]
[http://dx.doi.org/10.1186/s13058-019-1236-7] [PMID: 31856858]
[http://dx.doi.org/10.1016/j.ygyno.2015.07.098] [PMID: 26193427]
[http://dx.doi.org/10.3892/mmr.2021.11995] [PMID: 33760149]
[http://dx.doi.org/10.1093/humrep/dei414] [PMID: 16517565]
[http://dx.doi.org/10.1016/j.cell.2006.11.039] [PMID: 17218260]
[http://dx.doi.org/10.1093/humrep/deh571] [PMID: 15579491]
[http://dx.doi.org/10.1016/j.phymed.2023.155187] [PMID: 37984125]
[http://dx.doi.org/10.1186/s12964-024-01683-x] [PMID: 38858740]
[http://dx.doi.org/10.1177/1933719113488449] [PMID: 23653392]
[http://dx.doi.org/10.1016/j.fertnstert.2020.05.005] [PMID: 32762950]
[http://dx.doi.org/10.1016/j.tiv.2015.08.010] [PMID: 26318276]
[http://dx.doi.org/10.1186/s11658-022-00383-z] [PMID: 36180832]
[http://dx.doi.org/10.1016/j.vascn.2018.03.007] [PMID: 29630935]
[http://dx.doi.org/10.1007/s00018-013-1333-1] [PMID: 23579629]
[http://dx.doi.org/10.1007/s10540-005-2847-z] [PMID: 16222419]
[http://dx.doi.org/10.1111/all.12810] [PMID: 26606373]
[http://dx.doi.org/10.3390/ijms22179274] [PMID: 34502183]
[http://dx.doi.org/10.1093/humrep/deaa363] [PMID: 33378529]
[http://dx.doi.org/10.1038/s41420-022-00821-z] [PMID: 35039492]
[http://dx.doi.org/10.1186/s12929-021-00731-9] [PMID: 33962630]
[http://dx.doi.org/10.1016/j.fertnstert.2012.06.029] [PMID: 22819144]
[http://dx.doi.org/10.1016/S0140-6736(05)67063-8] [PMID: 16084259]
[http://dx.doi.org/10.3389/fmolb.2022.929832] [PMID: 35847989]
[PMID: 19969738]
[http://dx.doi.org/10.1007/978-3-319-18308-4_5]
[http://dx.doi.org/10.1016/j.fertnstert.2008.02.103] [PMID: 18396284]
[http://dx.doi.org/10.3109/00016349209021069] [PMID: 1326207]
[http://dx.doi.org/10.3390/biom12111702] [PMID: 36421722]
[http://dx.doi.org/10.1093/hropen/hoad033] [PMID: 37638130]
[http://dx.doi.org/10.1016/j.rbmo.2021.04.002] [PMID: 33992553]
[http://dx.doi.org/10.1093/molehr/gaad046] [PMID: 38113413]
[http://dx.doi.org/10.3389/fimmu.2021.671201] [PMID: 34539624]
[http://dx.doi.org/10.3389/fonc.2021.774648] [PMID: 34869021]
[http://dx.doi.org/10.3389/fphar.2023.1291773] [PMID: 38027016]
[http://dx.doi.org/10.3390/ijms22179182] [PMID: 34502089]
[http://dx.doi.org/10.4161/cc.26672] [PMID: 24107629]
[http://dx.doi.org/10.1016/j.bioorg.2021.104744] [PMID: 33639365]
[http://dx.doi.org/10.3389/fcell.2021.672335] [PMID: 34222246]
[http://dx.doi.org/10.1038/cdd.2009.84] [PMID: 19557014]
[http://dx.doi.org/10.1016/j.psyneuen.2014.06.015] [PMID: 25058273]
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- pubmed
- last seen: 2026-05-22T00:32:20.292070+00:00
- unpaywall
- last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine